| Progesterone from ovulatory menstrual cycles is an important cause of breast cancer HJT Coelingh Bennink, IJ Schultz, M Schmidt, VC Jordan, P Briggs, ... Breast Cancer Research 25 (1), 60, 2023 | 8 | 2023 |
| Changes in oral contraceptive design since the original release. Commentary on The biological history of the Pill by Roy O. Greep VD Castracane, VC Jordan Drug Action Haemodynamics and Immune Defence, 221-224, 2023 | | 2023 |
| Progress in the chemistry of agents to modulate reproduction. Commentary on The chemical history of the Pill by Carl Djerassi VC Jordan, VD Castracane Drug Action Haemodynamics and Immune Defence, 241-244, 2023 | | 2023 |
| Estrogen for the treatment and prevention of breast cancer: a tale of 2 Karnofsky lectures B Abderrahman, VC Jordan The Cancer Journal 28 (3), 163-168, 2022 | 6 | 2022 |
| Estrogen receptor complex to trigger or delay estrogen-induced apoptosis in long-term estrogen deprived breast cancer PY Maximov, P Fan, B Abderrahman, R Curpan, VC Jordan Frontiers in Endocrinology 13, 869562, 2022 | 4 | 2022 |
| Estrogen receptor and the unfolded protein response: double-edged swords in therapy for estrogen receptor-positive breast cancer P Fan, VC Jordan Targeted oncology 17 (2), 111-124, 2022 | 8 | 2022 |
| PERK, beyond an unfolded protein response sensor in estrogen-induced apoptosis in endocrine-resistant breast cancer P Fan, VC Jordan Molecular Cancer Research 20 (2), 193-201, 2022 | 25 | 2022 |
| Tamoxifen Tales: Suggestions for Scientific Survival VC Jordan Academic Press, 2022 | | 2022 |
| Turning scientific serendipity into discoveries in breast cancer research and treatment: a tale of PhD students and a 50-year roaming tamoxifen team VC Jordan Breast Cancer Research and Treatment 190 (1), 19-38, 2021 | 7 | 2021 |
| Rapid induction of the unfolded protein response and apoptosis by estrogen mimic TTC-352 for the treatment of endocrine-resistant breast cancer B Abderrahman, PY Maximov, RF Curpan, SW Fanning, JS Hanspal, ... Molecular cancer therapeutics 20 (1), 11-25, 2021 | 11 | 2021 |
| 50th anniversary of the first clinical trial with ICI 46,474 (tamoxifen): then what happened? VC Jordan Endocrine-related cancer 28 (1), R11-R30, 2021 | 35 | 2021 |
| Improving long-term adjuvant anti-oestrogenic therapy for breast cancer VC Jordan Evaluation 14, 34, 2020 | | 2020 |
| Assessing the safety of hormonal replacement therapy VC Jordan Evaluation 14, 34, 2020 | | 2020 |
| Breast cancer prevention trumps cure VC Jordan Evaluation 14, 34, 2020 | | 2020 |
| Chemoprevention in British women is inadequate VC Jordan Evaluation 14, 34, 2020 | | 2020 |
| Pharmacology and molecular mechanisms of clinically relevant estrogen estetrol and estrogen mimic BMI-135 for the treatment of endocrine-resistant breast cancer B Abderrahman, PY Maximov, RF Curpan, JS Hanspal, P Fan, R Xiong, ... Molecular Pharmacology 98 (4), 364-381, 2020 | 20 | 2020 |
| Molecular mechanism for breast cancer incidence in the Women's Health Initiative VC Jordan Cancer Prevention Research 13 (10), 807-816, 2020 | 18 | 2020 |
| Genome-wide DNA methylation changes in AI-resistant breast cancer models during E2-treatment R Hoppe, S Kandabarau, P Fan, S Winter, B Abderrahman, H Cunliffe, ... Cancer Research 80 (16_Supplement), 144-144, 2020 | 1 | 2020 |
| Serendipity in the search for “morning-after pills” led to clomiphene for the induction of ovulation VC Jordan F&S Science 1 (1), 3-13, 2020 | 1 | 2020 |
| Selective estrogen receptor modulators as a new postmenopausal prevention-maintenance therapy VC Jordan, JI MacGregor, DA Tonetti Progress in the Management of the Menopause: Proceedings of the 8th …, 2020 | 1 | 2020 |
